UNITED THERAPEUTICS Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q3 2024.
  • UNITED THERAPEUTICS Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 44.6M shares, a 4.9% decline year-over-year.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 46.8M shares, a 2.86% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 45.5M shares, a 1.34% increase from 2021.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 44.9M shares, a 1.58% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 44.6M -2.3M -4.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 44.4M -2.5M -5.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 47M +700K +1.51% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 46.8M +1.3M +2.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 46.9M +1.4M +3.08% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 46.9M +1.5M +3.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 46.3M +1.1M +2.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 45.5M +600K +1.34% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 45.5M +600K +1.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 45.4M +600K +1.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 45.2M +600K +1.35% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 44.9M +700K +1.58% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 44.9M +500K +1.13% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 44.8M +700K +1.59% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 44.6M +700K +1.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 44.2M +400K +0.91% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 44.4M +500K +1.14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 44.1M +300K +0.69% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 43.9M +200K +0.46% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 43.8M +300K +0.69% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 43.9M +300K +0.69% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 43.8M +700K +1.62% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 43.7M +400K +0.92% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 43.5M -500K -1.14% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 43.6M +200K +0.46% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 43.1M -1.8M -4.01% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 43.3M -1.2M -2.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 44M +200K +0.46% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 43.4M +200K +0.46% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 44.9M +600K +1.35% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 44.5M -900K -1.98% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 43.8M -2.2M -4.78% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 43.2M -2.3M -5.06% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 44.3M -1.8M -3.91% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 45.4M -1.3M -2.78% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 46M -2.2M -4.56% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 45.5M -1.8M -3.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 46.1M -1.52M -3.19% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 46.7M -3.7M -7.35% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 48.2M -1.88M -3.75% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 47.3M -2.72M -5.43% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 47.6M -2.18M -4.38% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-28
Q1 2014 50.4M +193K +0.38% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 50.1M -2.02M -3.87% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 50M -1.5M -2.91% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 49.8M -2.95M -5.59% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 50.2M -3.42M -6.38% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 52.1M -5.07M -8.87% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 51.5M -6.81M -11.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 52.7M -5.43M -9.34% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 53.6M -4.12M -7.14% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 57.2M +1.02M +1.82% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 58.3M +1.79M +3.16% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 58.2M +2.13M +3.81% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 57.8M +2.98M +5.45% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 56.1M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 56.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 56M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 54.8M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.